CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242,144 | -90.4% | 106,257 | -88.9% | 0.00% | -85.7% |
| Q2 2023 | $12,919,174 | -16.6% | 961,248 | +2.8% | 0.01% | -22.2% |
| Q1 2023 | $15,497,956 | -23.0% | 934,738 | -13.6% | 0.01% | -25.0% |
| Q4 2022 | $20,114,933 | +37.1% | 1,081,448 | -5.4% | 0.01% | +33.3% |
| Q3 2022 | $14,673,000 | +4116.4% | 1,143,651 | +2205.9% | 0.01% | – |
| Q2 2022 | $348,000 | -21.3% | 49,597 | -6.9% | 0.00% | – |
| Q1 2022 | $442,000 | +10.5% | 53,283 | -9.9% | 0.00% | – |
| Q4 2021 | $400,000 | +34.7% | 59,123 | +5.5% | 0.00% | – |
| Q3 2021 | $297,000 | -10.5% | 56,022 | -3.1% | 0.00% | – |
| Q2 2021 | $332,000 | +6.4% | 57,815 | -14.5% | 0.00% | – |
| Q1 2021 | $312,000 | +27.3% | 67,656 | -8.0% | 0.00% | – |
| Q4 2020 | $245,000 | +42.4% | 73,562 | +27.2% | 0.00% | – |
| Q3 2020 | $172,000 | -28.3% | 57,850 | +11.1% | 0.00% | – |
| Q2 2020 | $240,000 | -87.2% | 52,052 | -89.3% | 0.00% | -100.0% |
| Q1 2020 | $1,876,000 | +2.2% | 487,307 | -0.5% | 0.00% | +100.0% |
| Q4 2019 | $1,835,000 | +1156.8% | 489,579 | +1650.4% | 0.00% | – |
| Q3 2019 | $146,000 | -55.8% | 27,970 | -67.5% | 0.00% | – |
| Q2 2019 | $330,000 | -47.7% | 86,112 | -30.7% | 0.00% | – |
| Q1 2019 | $631,000 | +161.8% | 124,260 | -1.4% | 0.00% | – |
| Q4 2018 | $241,000 | -89.9% | 126,064 | -80.0% | 0.00% | -100.0% |
| Q3 2018 | $2,379,000 | +112.8% | 629,858 | +75.6% | 0.00% | – |
| Q2 2018 | $1,118,000 | -38.7% | 358,716 | -53.0% | 0.00% | -100.0% |
| Q1 2018 | $1,825,000 | -29.5% | 763,976 | +15.3% | 0.00% | -50.0% |
| Q4 2017 | $2,589,000 | +130.3% | 662,502 | +48.4% | 0.00% | +100.0% |
| Q3 2017 | $1,124,000 | -37.6% | 446,407 | -31.6% | 0.00% | 0.0% |
| Q2 2017 | $1,800,000 | +576.7% | 652,611 | +377.1% | 0.00% | – |
| Q1 2017 | $266,000 | +1562.5% | 136,788 | +811.9% | 0.00% | – |
| Q3 2016 | $16,000 | -93.5% | 15,000 | -95.7% | 0.00% | – |
| Q2 2016 | $245,000 | -52.0% | 345,445 | -21.0% | 0.00% | – |
| Q1 2016 | $510,000 | -41.5% | 437,146 | +22.6% | 0.00% | -100.0% |
| Q4 2015 | $872,000 | -60.7% | 356,430 | -51.8% | 0.00% | -50.0% |
| Q3 2015 | $2,218,000 | +32.4% | 739,904 | +82.3% | 0.00% | +100.0% |
| Q2 2015 | $1,675,000 | +59.7% | 405,901 | +67.4% | 0.00% | 0.0% |
| Q1 2015 | $1,049,000 | +48.6% | 242,493 | +2.0% | 0.00% | – |
| Q4 2014 | $706,000 | -10.5% | 237,800 | 0.0% | 0.00% | – |
| Q3 2014 | $789,000 | +526.2% | 237,800 | +375.6% | 0.00% | – |
| Q2 2014 | $126,000 | +11.5% | 50,000 | 0.0% | 0.00% | – |
| Q1 2014 | $113,000 | -21.5% | 50,000 | +5.2% | 0.00% | – |
| Q3 2013 | $144,000 | – | 47,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |